Begoña
López Salazar
Profesional Investigadora
Stanford University School of Medicine
Stanford, Estados UnidosPublicacións en colaboración con investigadores/as de Stanford University School of Medicine (3)
2020
-
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
Circulation, Vol. 141, Núm. 9, pp. 751-767
2019
-
Circulating biomarkers predicting longitudinal changes in left ventricular structure and function in a general population
Journal of the American Heart Association, Vol. 8, Núm. 2
2016
-
Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment
Nature Communications, Vol. 7